BTTC On Houston Radio Station
The Brain Tumor Trials Collaborative (BTTC) was created in 2003 as a network of medical centers with the expertise and the desire to participate in state-of-the-art clinical trials investigating new treatments for malignant brain tumors.
Dr. Mark Gilbert, Principal Investigator, Research Group for BTTC, and Terri Armstrong, Ph.D., Co-Principal Investigator and Director of Patient Outcomes Research for BTTC, were interviewed by Laurent Fouilloud-Buyat on Houston P.A. in October, 2013. They spoke about the BTTC, Head for the Cure, the advances in brain tumor research as well as what led them to their career paths.
Terri Armstrong said, “Many patients with a brain tumor don’t know anyone else with a brain tumor and they may feel alone. The medical community can also be the same. One of the benefits of BTTC is that it removed the isolation, bringing the most innovative treatments to the communities where patients live and allowing evaluation of treatment to be quicker because we work together and expand that way of thinking to all the centers and that is a really unique component of BTTC.”
The number of clinical trials available for people with brain tumors continues to grow, At this time, there are four clinical trials currently open for enrollment with three trials scheduled to be open in the next year. Dr. Mark Gilbert said, “The BTTC is comprised of colleagues who are collaborative. They are investigators who are the top of their game, but also good people.”
These trials hope to deliver results that provide a more effective treatment therapy in controlling the tumor and, ultimately, increasing survival.